Unity Biotechnology, Inc. designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells; and designs senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected.

Employee Rating

4.0More
TypePublic
HQSan Francisco, US
Founded2009
Size (employees)7 (est)
Websiteunitybiotechnology.com
UNITY Biotechnology was founded in 2009 and is headquartered in San Francisco, US
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at UNITY Biotechnology

Keith R. Leonard

Keith R. Leonard

CEO
Bob Goeltz

Bob Goeltz

CFO
Nathaniel David

Nathaniel David

President
Jamie Dananberg

Jamie Dananberg

Chief Medical Officer
D. Dan Marquess

D. Dan Marquess

Chief Scientific Officer
Tamara Tompkins

Tamara Tompkins

General Counsel
Show more

UNITY Biotechnology Office Locations

UNITY Biotechnology has an office in San Francisco
Show all (1)
Report incorrect company information

UNITY Biotechnology Financials and Metrics

UNITY Biotechnology Revenue

Market capitalization (16-Jan-2019)

674.2m

Closing stock price (16-Jan-2019)

15.9
UNITY Biotechnology's current market capitalization is $674.2 m.
Show all financial metrics
Report incorrect company information

UNITY Biotechnology Online and Social Media Presence

Embed Graph
Report incorrect company information

UNITY Biotechnology News and Updates

UNITY Biotechnology Announces Completion of UBX1967 License and Advance into IND-Enabling Studies for Age-Related Diseases of the Eye

SAN FRANCISCO, Jan. 03, 2019 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend human healthspan by slowing, halting or reversing diseases of aging, today announced it has selected UBX1967 as the lead development candidat…

UNITY Biotechnology, Inc. to Participate in the Morgan Stanley 16th Annual Global Healthcare Conference

SAN FRANCISCO, Sept. 05, 2018 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) (NASDAQ:UBX), a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging, today announced that Keith Leonard, chairman and chief executive officer, wil…
Report incorrect company information

UNITY Biotechnology Blogs

UNITY Biotechnology, Inc. Appoints Margo Roberts Ph.D. to Board of Directors

UNITY Biotechnology, Inc. Appoints Margo Roberts Ph.D. to Board of Directors Content Import Tue, 12/04/2018 - 08:04 UNITY Biotechnology, Inc. Appoints Margo Roberts Ph.D. to Board of Directors December 4, 2018 at 8:00 AM EST This release is a backfill from a N…

Salim Sayed

Salim Sayed ma.celeste.loy… Fri, 11/16/2018 - 19:47 Salim Sayed Mizuho Securities

UNITY Biotechnology, Inc. to Host Investor & Analyst Event on Cellular Senescence

- Event will be webcast live - SAN FRANCISCO , Nov. 13, 2018 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging, today announced that it will host an Investor &a…

UNITY Biotechnology, Inc. Reports Third Quarter 2018 Financial Results

SAN FRANCISCO , Nov. 07, 2018 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging, today reported third quarter 2018 financial results.

UNITY Biotechnology, Inc. to Announce Third Quarter 2018 Financial Results

SAN FRANCISCO , Oct. 31, 2018 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) (NASDAQ:UBX), a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging, plans to report results for the third quarter ended September 30, 2018 , on

UNITY Biotechnology, Inc. to Participate in the Cantor Fitzgerald Annual Global Healthcare Conference

UNITY Biotechnology, Inc. to Participate in the Cantor Fitzgerald Annual Global Healthcare Conference Content Import Mon, 09/24/2018 - 16:07 UNITY Biotechnology, Inc. to Participate in the Cantor Fitzgerald Annual Global Healthcare Conference September 24, 2018 at 4:05 PM ED…

UNITY Biotechnology Company Life and Culture

Report incorrect company information

UNITY Biotechnology Frequently Asked Questions

  • When was UNITY Biotechnology founded?

    UNITY Biotechnology was founded in 2009.

  • Who are UNITY Biotechnology key executives?

    UNITY Biotechnology's key executives are Keith R. Leonard, Bob Goeltz and Nathaniel David.

  • How many employees does UNITY Biotechnology have?

    UNITY Biotechnology has 7 employees.

  • Who are UNITY Biotechnology competitors?

    Competitors of UNITY Biotechnology include Syneos Health, Deciphera Pharmaceuticals and Innovation Pharmaceuticals.

  • Where are UNITY Biotechnology offices?

    UNITY Biotechnology has an office in San Francisco.

  • How many offices does UNITY Biotechnology have?

    UNITY Biotechnology has 1 office.